Who Just Raised

NurExone Biologic Inc.

Technion City, Haifa, Israel ยท Biotechnology

NurExone Biologic Inc. is a biotechnology company based in Technion City, Haifa, Israel. In a Form D filed with the SEC on August 21, 2026, it reported raising $450,456 from 2 investors as part of an offering of up to $450,456. The first sale in the offering took place on August 20, 2026.

Amount raised
$450,456
Offering size
$450,456
Investors so far
2
First sale
August 20, 2026
Securities offered
Equity, Options or warrants, Securities issuable on exercise or conversion
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Technion City, Haifa, Israel
Incorporated
Ontario, Canada, 2025
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $450,456 $450,456 2 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises

Company Location Sector Raised Target Filed
Curadel Surgical Innovations, Inc. Bonita Springs, FL Health Care $49.8M $57.5M
Axelyf, Inc. Chestnut Hill, MA Health Care $2.6M $2.7M
iPill Inc. Rowland Heights, CA Health Care $1.3M $1.5M
Dvant Pharma, Inc. Superior Township, MI Health Care $1.2M $3.1M
FibroBiologics, Inc. Houston, TX Health Care $1.2M $1.2M
Vimy Pharmaceuticals Inc. Toronto, Ontario, Canada Health Care $1M $1M